Urgent.News

What's breaking now, across thousands of outlets.

Science

GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people

Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention & Health.

GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people

A small study published in BMJ Nutrition Prevention & Health has found that appetite suppressant drugs, such as Wegovy and Mounjaro, may lead to inadequate consumption of key nutrients and energy in some individuals. Despite their effectiveness in treating obesity and type 2 diabetes, there is limited understanding of their impact on dietary intake.

Researchers surveyed 14 patients prescribed these drugs in England, asking them to log their food intake for two days. Average daily energy intake was found to be 1,231 kcal, or 58.5% of recommended levels. Below RNI intake was observed in 10 people for 28 nutrients, including protein, fiber and vitamin D. Eight participants fell short of recommended levels for three or more nutrients.

The findings highlight a gap in professional oversight and nutritional support for patients on these drugs, particularly outside NHS pathways.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Science

More from Tuesday 17 November →